162. 類天疱瘡(後天性表皮水疱症を含む。) Pemphigoid Clinical trials / Disease details


臨床試験数 : 83 薬物数 : 129 - (DrugBank : 51) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 142

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05263505
(ClinicalTrials.gov)
February 21, 202216/2/2022Baricitinib for the Treatment of Ocular Mucous Membrane PemphigoidBaricitinib for the Treatment of Ocular Mucous Membrane PemphigoidMucous Membrane Pemphigoid;Cicatrizing ConjunctivitisDrug: Baricitinib 2 MG [Olumiant];Drug: Methotrexate;Drug: Azathioprine;Drug: MycophenolateWashington University School of MedicineEli Lilly and CompanyRecruiting18 YearsN/AAll20Phase 2United States